SMTL ID : 5aa9.1

Structure of L1198F Mutant Human Anaplastic Lymphoma Kinase in Complex with PF-06463922 ((10R)-7-amino-12-fluoro-2,10,16-trimethyl- 15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile).

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.93 Å

Oligo State

monomer

Ligands

1 x 5P8: (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile(Non-covalent)

5P8.1: 16 residues within 4Å: Chain A: L.38, G.39, V.46, A.64, L.112, E.113, F.114, M.115, A.116, G.118, D.119, R.169, N.170, L.172, G.185, D.186 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.112, A:L.172 Hydrogen bonds: A:E.113, A:M.115 Water bridges: A:D.119 Halogen bonds: A:N.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shaw, A.T. et al., Resensitization to Crizotinib by the Lorlatinib Alk Resistance Mutation L1198F. N.Engl.J.Med. (2016)

Release Date

2016-06-08

Peptides

ALK TYROSINE KINASE RECEPTOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK TYROSINE KINASE RECEPTOR

Related Entries With Identical Sequence